Click below to register.
Saturday, November 18, 2017
Sheraton Inner Harbor
300 South Charles St
Baltimore, MD
Room: Harborview Ballroom
7:30 AM – 8:00 AM: Registration and Breakfast
8:00 AM – 12:30 PM: Interactive CME/CNE Activity
Multiple sclerosis (MS) has been long considered an inflammatory and demyelinating disease of the central nervous system that is associated with axonal loss and neurodegeneration. However, it is a highly heterogeneous disease with regard to presenting symptoms, disease activity, relapse rate, and rate of disability progression. Although there is no cure for MS, current and emerging targeted treatments aim to slow disease progression, reduce relapses, and limit disability. Many uncertainties remain in the diagnosis, treatment, and overall management of patients with MS: How to recognize symptoms and accurately diagnose MS? Which diagnostic tests should be performed? Which therapies should be used? When to initiate, switch, and/or discontinue treatment? How to optimally manage symptoms while minimizing treatment side effects and improving patient’s health-related quality of life? This interactive live symposium series will bring together MS experts to present and discuss the latest diagnostic approaches and treatment strategies for optimizing the management of and improving outcomes for patients with MS. This program will include breakout sessions to discuss case studies from the perspectives of the neurologist, the MS specialty nurse, and the primary care provider.
The goal of this program is to provide neurologists, primary care physicians, nurse practitioners, physician assistants, nurses and other healthcare providers who treat patients with MS with the latest science and clinical issues related to the management of MS as well as the opportunity to discuss cases with local MS experts.
This activity is designed for neurologists, primary care physicians, nurses and other healthcare providers who treat patients with MS.
After attending this activity, participants will demonstrate the ability to:
- SUMMARIZE common presentations of MS and its differential diagnoses.
- DISCUSS efficacy and safety data of emerging and currently available therapies.
- RECOGNIZE and manage MS-related symptoms.
- IMPLEMENT individualized MS diagnosis and management plans.
The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing take responsibility for the content, quality, and scientific integrity of this CME/CNE activity.
 This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This 4.0 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity.
| 7:30 – 8:00 AM |
Registration, Breakfast, and Networking at MS Advocacy Exhibit |
| 8:00 – 8:15 AM |
Conference Goals and Pre-assessment |
| 8:15 – 9:00 AM |
Overview and Diagnosis – Red Flags for Misdiagnosis of MS
|
| 9:00 – 10:00 AM |
Managing Symptoms Associated with MS
(Featuring Content Selection) |
| 10:00 – 10:30 AM |
Break and Networking at MS Advocacy Exhibit |
| 10:30 – 12:15 PM |
Educational Breakout Sessions: Case Studies |
|
Track 1: Neurologists/Specialty Nurses’ Perspectives |
|
Track 2: Primary Care Provider Perspectives |
| 12:15 – 12:30 PM |
Activity Conclusion and Post-assessment |
This schedule is subject to change.
|
Kathleen Costello, MS, ANP-BC, MSCN
(Co-Chair)
Nurse Practitioner
Johns Hopkins Multiple Sclerosis Center
Associate Vice President Healthcare Access
National MS Society
Baltimore, Maryland
Benjamin M. Greenberg, MD, MHS, FANA, FAAN
Director, Transverse Myelitis, Neuromyelitis Optica Programs
Director, Neurosciences Translational Research Center
Co-Director, Pediatric CONQUER Program
UT Southwestern Medical Center
Childrens Health
Dallas, Texas
|
Scott Newsome, DO, MSCS, FAAN (Co-Chair)
Associate Professor of Neurology
Director, Neurology Outpatient Services
Director, Neurology Infusion Center
Director, Stiff Person Syndrome Center
Member, Miller-Coulson Academy of Clinical Excellence
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
|
Fred D. Lublin, MD, FAAN, FANA
Saunders Family Professor of Neurology
Director, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Co-Chief Editor, Multiple Sclerosis and Related Disorders
Icahn School of Medicine at Mount Sinai
New York, New York
|
Myla D. Goldman, MD, MSc
Director, MS Clinic
Associate Professor of Neurology
University of Virginia School of Medicine
Charlottesville, VA
|
It is the policy of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing that the speaker and provider globally disclose conflicts of interest. Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosures will be made in the instructional materials.
It is the policy of the Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program. Detailed disclosures will be made in the course materials.
Please note: The Physician Payments Sunshine Act was enacted by Congress to increase public awareness of financial relationships between drug and medical device manufacturers and physicians. In compliance with the requirements of this Act, the commercial supporter/s of this activity may require the Johns Hopkins University School of Medicine to report certain professional information (such as name, address, National Provider Identifier, and State License #) of physician attendees who receive complimentary food and beverage in conjunction with a CME activity. The commercial supporter is required to submit the collected data to the Centers for Medicare and Medicaid Services which will then publish the data on its website.
The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing fully comply with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
There is no fee for this educational activity.
Please select a topic you would like featured at the event:
Fatigue
Cognitive dysfunction
Depression
Pain
Bladder dysfunction
Impairments in mobility
|